Commerzbank Aktiengesellschaft FI Buys 4,514 Shares of CME Group Inc. (NASDAQ:CME)

Commerzbank Aktiengesellschaft FI boosted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 10.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 47,355 shares of the financial services provider's stock after purchasing an additional 4,514 shares during the quarter. Commerzbank Aktiengesellschaft FI's holdings in CME Group were worth $10,449,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CME. Capital International Investors boosted its holdings in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. boosted its stake in CME Group by 137.6% in the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock worth $444,443,000 after purchasing an additional 1,309,097 shares during the period. M&G Plc bought a new position in CME Group during the 1st quarter worth about $156,631,000. Assenagon Asset Management S.A. increased its holdings in CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock worth $126,872,000 after purchasing an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the period. Institutional investors own 87.75% of the company's stock.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the firm's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company's stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business's stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company's stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

Shares of NASDAQ CME opened at $224.81 on Wednesday. The business's 50 day moving average is $217.70 and its 200-day moving average is $208.53. The firm has a market cap of $80.95 billion, a P/E ratio of 25.73, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.12. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business's revenue was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.30 EPS. Equities research analysts predict that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.05%. CME Group's payout ratio is 52.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CME shares. Oppenheimer upped their price target on CME Group from $228.00 to $245.00 and gave the stock an "outperform" rating in a research report on Monday, October 14th. Redburn Atlantic lowered shares of CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price objective on the stock. in a research report on Tuesday, October 8th. Piper Sandler raised their target price on shares of CME Group from $225.00 to $240.00 and gave the company an "overweight" rating in a research report on Tuesday, October 8th. Citigroup lifted their price target on shares of CME Group from $240.00 to $250.00 and gave the company a "buy" rating in a research note on Thursday, October 3rd. Finally, The Goldman Sachs Group increased their price objective on shares of CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a research note on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $220.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.